EUVIMEDEUVIMED entdecken
Crossref

Gasotransmitter nitric oxide imaging in Alzheimer's disease and glioblastoma with diamino-cyclic-metalloiridium phosphorescence probes

Haitao Ding, Li Luo, Liping Su, Junyang Chen, Yunkun Li, Lei Hu, Kui Luo, Xiaohe Tian

Biosensors and Bioelectronics · 2024

DOI: 10.1016/j.bios.2023.115939 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biosensors and Bioelectronics, 2024. Verfasst von Haitao Ding und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology and National Clinical Research Center for Geriatrics, Huaxi MR Research Center (HMRRC), Frontiers Science Center for Disease-…. Hauptthemen laut MEDLINE: Alzheimer Disease, Gasotransmitters, Glioblastoma, Biosensing Techniques. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 35 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Nitric Oxide (NO), a significant gasotransmitter in biological systems, plays a crucial role in neurological diseases and cancer. Currently, there is a lack of effective methods for rapidly and sensitively identifying NO and elucidating its relationship with neurological diseases. Novel diamino-cyclic-metalloiridium phosphorescence probes, Ir-CDA and Ir-BDA, have been designed to visualize the gasotransmitter NO in Alzheimer's disease (AD) and glioblastoma (GBM). Ir-CDA and Ir-BDA utilize iridium (III) as the central ion and incorporate a diamino group as a ligand. The interaction between the diamino structure and NO leads to the formation of a three-nitrogen five-membered ring structure, which opens up phosphorescence. The two probes can selectively bind to NO and offer low detection limits. Additionally, Ir-BDA/Ir-CDA can image NO in brain cancer cell models, neuroinflammatory models, and AD cell models. Furthermore, the NO content in fresh brain sections from AD mice was considerably higher than that in wild-type (WT) mice. Consequently, it is plausible that NO is generated in significant quantities around cells hosting larger Aβ deposits, gradually diffusing throughout the entire brain region. Furthermore, we posit that this phenomenon is a key factor contributing to the higher brain NO content in AD mice compared to that in WT mice. This discovery offers novel insights into the diagnosis and treatment of AD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseGasotransmittersGlioblastomaBiosensing TechniquesMiceAnimalsNitric OxideDisease Models, AnimalAmyloid beta-Peptides

Stichwörter der Autor:innen

Alzheimer's diseaseBioimagingDiamino-cyclic-metalloiridiumGasotransmitterGlioblastomaNitric oxide

Substanzen

Nitric OxideGasotransmittersAmyloid beta-Peptides

Autor:innen und Institutionen

  • Department of Radiology and National Clinical Research Center for Geriatrics, Huaxi MR Research Center (HMRRC), Frontiers Science Center for Disease-Related Molecular Network, State Key Laboratory of Biotherapy, West Ch…
  • The Center of Gerontology and Geriatrics, National Clinical Research Center for Geriatrics, West China Hospital of Sichuan University, Chengdu 610000, Sichuan Province, China.
  • Department of Chemistry, University College London, London, United Kingdom.
  • School of Pharmacy, Wannan Medical College, Wuhu 241002, China.

Zitieren

APA

Ding, H., Luo, L., Su, L., Chen, J., Li, Y., Hu, L., Luo, K., & Tian, X. (2024). Gasotransmitter nitric oxide imaging in Alzheimer's disease and glioblastoma with diamino-cyclic-metalloiridium phosphorescence probes. Biosensors and Bioelectronics. https://doi.org/10.1016/j.bios.2023.115939

Vancouver

Ding H, Luo L, Su L, Chen J, Li Y, Hu L, et al. Gasotransmitter nitric oxide imaging in Alzheimer's disease and glioblastoma with diamino-cyclic-metalloiridium phosphorescence probes. Biosensors and Bioelectronics. 2024. doi:10.1016/j.bios.2023.115939

BibTeX
@article{Ding2024,
  author = {Ding, Haitao and Luo, Li and Su, Liping and Chen, Junyang and Li, Yunkun and Hu, Lei and Luo, Kui and Tian, Xiaohe},
  title = {Gasotransmitter nitric oxide imaging in Alzheimer's disease and glioblastoma with diamino-cyclic-metalloiridium phosphorescence probes},
  journal = {Biosensors and Bioelectronics},
  year = {2024},
  doi = {10.1016/j.bios.2023.115939}
}
Kostenlos starten →